Amélie Boespflug

1.3k total citations
21 papers, 340 citations indexed

About

Amélie Boespflug is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amélie Boespflug has authored 21 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amélie Boespflug's work include Cancer Immunotherapy and Biomarkers (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Melanoma and MAPK Pathways (5 papers). Amélie Boespflug is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Melanoma and MAPK Pathways (5 papers). Amélie Boespflug collaborates with scholars based in France, Switzerland and Australia. Amélie Boespflug's co-authors include L. Thomas, Stéphane Dalle, Julien Péron, Marie Perier‐Muzet, Pauline Corbaux, Denis Maillet, M. Duruisseaux, Claire Falandry, M. Locatelli-Sanchez and Julie Caramel and has published in prestigious journals such as Cancer Research, Journal of the American Academy of Dermatology and European Journal of Cancer.

In The Last Decade

Amélie Boespflug

20 papers receiving 336 citations

Peers

Amélie Boespflug

ONCOL

PRM

IMMUN

SURGE

Paul M. Diderichsen United States

Francesca Aroldi Italy

Silvia Marchetti Italy

Gary Altwerger United States

Karan Rai United States

Lucia Bonomi Italy

P.A. Ascierto Italy

Volker Krieg Germany

Graziela Zibetti Dal Molin Brazil

Paul M. Diderichsen United States

Amélie Boespflug

119 ×0.5

ONCOL

60 ×0.6

PRM

101 ×1.2

45 ×0.8

IMMUN

31 ×1.0

SURGE

Citations per year, relative to Amélie Boespflug Amélie Boespflug (= 1×) peers Paul M. Diderichsen

Countries citing papers authored by Amélie Boespflug

Since Specialization

Citations

This map shows the geographic impact of Amélie Boespflug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Boespflug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Boespflug more than expected).

Fields of papers citing papers by Amélie Boespflug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Boespflug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Boespflug. The network helps show where Amélie Boespflug may publish in the future.

Co-authorship network of co-authors of Amélie Boespflug

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Boespflug. A scholar is included among the top collaborators of Amélie Boespflug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Boespflug. Amélie Boespflug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Péron, Julien, Stéphane Dalle, Amélie Boespflug, et al.. (2022). Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines. 11(1). 83–83. 6 indexed citations

Boespflug, Amélie, et al.. (2021). Paraneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma. The Lancet Haematology. 8(3). e240–e240. 4 indexed citations

Souquet, Pierre-Jean, Stéphane Dalle, Pauline Corbaux, et al.. (2021). Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers. 13(10). 2365–2365. 15 indexed citations

Boespflug, Amélie, Delphine Maucort‐Boulch, Charles‐Hervé Vacheron, et al.. (2021). Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma. Cancer Medicine. 10(10). 3155–3164. 6 indexed citations

Maillet, Denis, Pauline Corbaux, Jean‐Jacques Stelmes, et al.. (2020). Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors. European Journal of Cancer. 132. 61–70. 56 indexed citations

Corbaux, Pauline, Denis Maillet, Amélie Boespflug, et al.. (2019). Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting. European Journal of Cancer. 121. 192–201. 58 indexed citations

Bouhamama, Amine, et al.. (2018). Percutaneous Cryotherapy for Treatment of Chondroblastoma: Early Experience. CardioVascular and Interventional Radiology. 42(2). 304–307. 10 indexed citations

Kinsey, Conan G., Katrin P. Guillen, Soledad A. Camolotto, et al.. (2018). Abstract LB-254: Combined inhibition of MEK and autophagy promotes regression of pancreatic cancer. Cancer Research. 78(13_Supplement). LB–254. 1 indexed citations

Kaya, Gürkan, Aysin Kaya, Olivier Sorg, et al.. (2018). RASopathic comedone‐like or cystic lesions induced by vemurafenib: a model of skin lesions similar but not identical to those induced by dioxins MADISH. Journal of the European Academy of Dermatology and Venereology. 32(8). 1368–1372. 1 indexed citations

10.

Boespflug, Amélie, et al.. (2018). Dermatoscopia de las lesiones cutáneas no neoplásicas. 52(1). 1–9. 2 indexed citations

11.

Tschandl, Philipp, Alessio Gambardella, Amélie Boespflug, et al.. (2017). Seven Non-melanoma Features to Rule Out Facial Melanoma. Acta Dermato Venereologica. 97(10). 1219–1224. 15 indexed citations

12.

Boespflug, Amélie, S. Debarbieux, L. Depaepe, et al.. (2017). Association of subungual melanoma and subungual squamous cell carcinoma: A case series. Journal of the American Academy of Dermatology. 78(4). 760–768. 2 indexed citations

13.

Perier‐Muzet, Marie, Julien Péron, Claire Falandry, et al.. (2017). Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma. JAMA Dermatology. 154(1). 82–82. 52 indexed citations

14.

Boespflug, Amélie & L. Thomas. (2016). Cobimetinib and vemurafenib for the treatment of melanoma. Expert Opinion on Pharmacotherapy. 17(7). 1005–1011. 27 indexed citations

15.

Ranchon, Florence, Amélie Boespflug, Catherine Rioufol, et al.. (2015). New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies. Anti-Cancer Agents in Medicinal Chemistry. 15(4). 461–467. 7 indexed citations

16.

Boespflug, Amélie, José Guerra, Stéphane Dalle, & L. Thomas. (2015). Enhancement of Customary Dermoscopy Education With Spaced Education e-Learning. JAMA Dermatology. 151(8). 847–847. 23 indexed citations

17.

Boespflug, Amélie, et al.. (2012). Enregistrement et publication du critère d’évaluation principal dans les essais contrôlés randomisés en oncologie. Bulletin du Cancer. 99(10). 943–952. 3 indexed citations

18.

Quoc, C. Ho, et al.. (2012). Reconstruction fessière esthétique fiabilisée par une artère perforante glutéale. Annales de Chirurgie Plastique Esthétique. 58(4). 347–351. 1 indexed citations

19.

Boespflug, Amélie, Pierre‐Paul Bringuier, Sylvie Isaac, et al.. (2012). Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): Routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L. Lung Cancer. 79(3). 318–320. 8 indexed citations

20.

Boespflug, Amélie, Stéphane Dalle, & L. Thomas. (2012). Mélanome mimant un nævus de Reed. Annales de Dermatologie et de Vénéréologie. 139(12). 857–858.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact